Kovari D, Male L, Roper K, Mang C, Kunz O, Cox L
J Org Chem. 2025; 90(7):2652-2661.
PMID: 39927818
PMC: 11852203.
DOI: 10.1021/acs.joc.4c02690.
Chen B, Sun M, Zhang C, Huang Q, Teng D, Hu L
J Med Chem. 2024; 67(23):21009-21029.
PMID: 39574384
PMC: 11647907.
DOI: 10.1021/acs.jmedchem.4c01605.
Zhou T, Zhang Z, Nie J, Kwong F, Ma J, Cheung C
Nat Commun. 2024; 15(1):9926.
PMID: 39548078
PMC: 11568185.
DOI: 10.1038/s41467-024-53828-8.
Tan J, Kang Y, Hartwig J
Nat Commun. 2024; 15(1):8307.
PMID: 39333063
PMC: 11437150.
DOI: 10.1038/s41467-024-52245-1.
Elias M, Aputen A, Fatima S, Mann T, Karan S, Mikhael M
Int J Mol Sci. 2024; 25(15).
PMID: 39125821
PMC: 11312340.
DOI: 10.3390/ijms25158252.
Identification of 6-Anilino Imidazo[4,5-]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers.
Hong C, Liew L, Wong W, Dickson B, Cheng G, Shome A
J Med Chem. 2024; 67(14):12366-12385.
PMID: 39007759
PMC: 11284801.
DOI: 10.1021/acs.jmedchem.4c01120.
Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models.
Spassov D
Int J Mol Sci. 2024; 25(13).
PMID: 39000229
PMC: 11240957.
DOI: 10.3390/ijms25137124.
Regio- and Enantioselective Hydromethylation of 3-Pyrrolines and Glycals Enabled by Cobalt Catalysis.
Shen M, Niu C, Wang X, Huang J, Zhao Z, Ni S
JACS Au. 2024; 4(6):2312-2322.
PMID: 38938800
PMC: 11200246.
DOI: 10.1021/jacsau.4c00275.
Methyl-Containing Pharmaceuticals.
Illuminati D, Fantinati A
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794133
PMC: 11124427.
DOI: 10.3390/ph17050563.
Inhibitor Trapping in Kinases.
Spassov D, Atanasova M, Doytchinova I
Int J Mol Sci. 2024; 25(6).
PMID: 38542228
PMC: 10970472.
DOI: 10.3390/ijms25063249.
A Computational Method for the Binding Mode Prediction of COX-1 and COX-2 Inhibitors: Analyzing the Union of Coxibs, Oxicams, Propionic and Acetic Acids.
Bello-Vargas E, Leyva-Peralta M, Gomez-Sandoval Z, Ordonez M, Razo-Hernandez R
Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139814
PMC: 10747940.
DOI: 10.3390/ph16121688.
Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport.
Kaku K, Ravindra M, Tong N, Choudhary S, Li X, Yu J
ACS Med Chem Lett. 2023; 14(12):1682-1691.
PMID: 38116433
PMC: 10726441.
DOI: 10.1021/acsmedchemlett.3c00326.
Stereoselective RNA reaction with chiral 2'-OH acylating agents.
Shioi R, Xiao L, Chatterjee S, Kool E
Chem Sci. 2023; 14(45):13235-13243.
PMID: 38023505
PMC: 10664579.
DOI: 10.1039/d3sc03067a.
Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor.
Yano H, Chitsazi R, Lucaj C, Tran P, Hoffman A, Baumann M
ACS Chem Neurosci. 2023; 14(21):3928-3940.
PMID: 37847546
PMC: 10623572.
DOI: 10.1021/acschemneuro.3c00530.
Electrochemical Late-Stage Functionalization.
Wang Y, Dana S, Long H, Xu Y, Li Y, Kaplaneris N
Chem Rev. 2023; 123(19):11269-11335.
PMID: 37751573
PMC: 10571048.
DOI: 10.1021/acs.chemrev.3c00158.
Unravelling Surface Modification Strategies for Preventing Medical Device-Induced Thrombosis.
Luu C, Nguyen N, Ta H
Adv Healthc Mater. 2023; 13(1):e2301039.
PMID: 37725037
PMC: 11468451.
DOI: 10.1002/adhm.202301039.
The Magic Methyl and Its Tricks in Drug Discovery and Development.
Pinheiro P, Franco L, Fraga C
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37631072
PMC: 10457765.
DOI: 10.3390/ph16081157.
Discovery of "Molecular Switches" within a Series of mGlu Allosteric Ligands Driven by a "Magic Methyl" Effect Affording Both PAMs and NAMs with Activity, Derived from an M PAM Chemotype.
Barbaro L, Rodriguez A, Blevins A, Dickerson J, Billard N, Boutaud O
ACS Bio Med Chem Au. 2023; 1(1):21-30.
PMID: 37101980
PMC: 10114714.
DOI: 10.1021/acsbiomedchemau.1c00024.
Late-stage functionalization of 5-nitrofurans derivatives and their antibacterial activities.
Chen G, Chang Z, Yuan P, Wang S, Yang Y, Liang X
RSC Adv. 2023; 13(5):3204-3209.
PMID: 36756397
PMC: 9853512.
DOI: 10.1039/d2ra07676d.
Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation.
Xie H, Li C, Tang H, Tandon I, Liao J, Roberts B
J Med Chem. 2023; 66(4):2904-2917.
PMID: 36749666
PMC: 10398712.
DOI: 10.1021/acs.jmedchem.2c01941.